Physician profile
Nathan Boes
NPI 1538513916
$71,199.34
in general payments reported to CMS, 2019-2025
19 companies · $2,605 in 2025
The $2,605 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,295 · 2021: $30K · 2022: $33K · 2023: $3,778 · 2024: $467 · 2025: $2,605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,694 · Food and Beverage: $3,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,693.63 |
| Food and Beverage | $3,155.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $25,731.60 | 2021-2023 | Knee & Hip Implants Meniscal Repair Fiberstitch |
| Pylant Medical | $14,714.97 | 2019-2024 | |
| Peerless Surgical INC. | $7,244.81 | 2021-2022 | |
| Smith+Nephew, INC. | $6,983.11 | 2021-2025 | Acufex Meniscal Root Repair, Q-Fix, Healicoil |
| Medical Device Business Services, INC. | $6,083.33 | 2021 | |
| Djo, LLC | $3,750.00 | 2022 | |
| Encore Medical, LP | $2,906.74 | 2022 | |
| Stryker Corporation | $1,164.97 | 2022-2025 | Mako, Iconix, Blueprint Patient Specific Instrumentation |
| Medacta USA, INC. | $755.69 | 2022 | |
| International Life Sciences | $661.25 | 2023 | |
| Goode Surgical INC | $249.02 | 2023 | |
| Catalyst Orthoscience | $235.98 | 2024-2025 | Catalyst Csr Shoulder System, R1 Reverse Shoulder System |
| Avanos Medical | $210.42 | 2022 | |
| Zimmer Biomet Holdings, INC. | $148.67 | 2022 | |
| Exactech, INC. | $140.91 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Breg, INC | $132.58 | 2022 | |
| Bodycad USA Corp | $51.31 | 2023 | Fine Osteotomy |
| Ferring Pharmaceuticals INC. | $20.53 | 2023 | Euflexxa |
| Depuy Synthes Sales INC. | $13.45 | 2023 | Inhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Boes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.